IL143332A0 - Scavenger compounds - Google Patents
Scavenger compoundsInfo
- Publication number
- IL143332A0 IL143332A0 IL14333299A IL14333299A IL143332A0 IL 143332 A0 IL143332 A0 IL 143332A0 IL 14333299 A IL14333299 A IL 14333299A IL 14333299 A IL14333299 A IL 14333299A IL 143332 A0 IL143332 A0 IL 143332A0
- Authority
- IL
- Israel
- Prior art keywords
- compounds
- scavenger compounds
- ros
- scavenging
- properties
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655345—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a five-membered ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/02—Five-membered rings
- C07D339/04—Five-membered rings having the hetero atoms in positions 1 and 2, e.g. lipoic acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D339/00—Heterocyclic compounds containing rings having two sulfur atoms as the only ring hetero atoms
- C07D339/08—Six-membered rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic System
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/6553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms
- C07F9/655363—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having sulfur atoms, with or without selenium or tellurium atoms, as the only ring hetero atoms the sulfur atom being part of a six-membered ring
Abstract
The present invention provides novel compounds having scavenging and anti-ROS properties and pharmaceutical composition comprising these compounds for treatment of conditions associated with oxidative stress or free radical injury. The compounds of the invention are of general formula (I).
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US11003798P | 1998-11-25 | 1998-11-25 | |
PCT/IL1999/000638 WO2000031060A1 (en) | 1998-11-25 | 1999-11-25 | Scavenger compounds |
Publications (1)
Publication Number | Publication Date |
---|---|
IL143332A0 true IL143332A0 (en) | 2002-04-21 |
Family
ID=22330899
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
IL14333299A IL143332A0 (en) | 1998-11-25 | 1999-11-25 | Scavenger compounds |
Country Status (9)
Country | Link |
---|---|
US (1) | US6900338B1 (en) |
EP (1) | EP1133487B1 (en) |
JP (1) | JP2002530396A (en) |
AT (1) | ATE276241T1 (en) |
AU (1) | AU775388B2 (en) |
CA (1) | CA2352144A1 (en) |
DE (1) | DE69920260T2 (en) |
IL (1) | IL143332A0 (en) |
WO (1) | WO2000031060A1 (en) |
Families Citing this family (25)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6310052B1 (en) | 1996-06-04 | 2001-10-30 | Queen's University At Kingston | Nitrate esters and their use for neurological conditions |
US6365623B1 (en) * | 1997-11-17 | 2002-04-02 | Nicholas V. Perricone | Treatment of acne using lipoic acid |
GB9801398D0 (en) | 1998-01-22 | 1998-03-18 | Anggard Erik E | Chemical compounds |
WO2001009118A2 (en) * | 1999-07-29 | 2001-02-08 | Patrick T Prendergast | Dithiolthione compounds for the treatment of neurological disorders and for memory enhancement |
DE10027968A1 (en) * | 2000-06-08 | 2001-12-13 | Asta Medica Ag | Adjuvant therapy of dementia using alpha-lipoic acid or derivative, is effective in combination with antidementia or neurotransmission improving agents in improving cognitive function in e.g. Alzheimer's disease patients |
AU2003208767A1 (en) * | 2002-03-05 | 2003-09-16 | Universitaet Ulm | Dithiolane derivatives for immobilizing biomolecules on noble metals and semiconductors |
DE60302454T2 (en) | 2002-04-19 | 2006-08-17 | Yissum Research Development Company Of The Hebrew University Of Jerusalem | BETA AGONISTS COMPOUNDS WITH STICK OXIDE DONATOR GROUPS AND REACTIVE OXYGEN SPECIES CATEGORIES AND THEIR USE IN THE TREATMENT OF AIRWAY FLUCTUATIONS |
EP2125775A4 (en) * | 2007-03-01 | 2011-07-13 | Cedars Sinai Medical Center | Antioxidant polymers containing [1,2]-dithiolane moieties and uses thereof |
KR20090117950A (en) | 2007-03-08 | 2009-11-16 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
DE102007038849A1 (en) * | 2007-08-16 | 2009-02-19 | Adscil Gmbh | Use of R (+) - alpha lipoic acid for the treatment of cryptogenic neuropathy |
WO2009086547A1 (en) * | 2008-01-03 | 2009-07-09 | Cedars-Sinai Medical Center | Antioxidant nanosphere comprising [1,2]-dithiolane moieties |
EP2300451A1 (en) | 2008-06-02 | 2011-03-30 | Cedars-Sinai Medical Center | Nanometer-sized prodrugs of nsaids |
WO2010028175A1 (en) | 2008-09-08 | 2010-03-11 | The Board Of Trustees Of The Leland Stanford Junior University | Modulators of aldehyde dehydrogenase activity and methods of use thereof |
JP2012506856A (en) | 2008-10-28 | 2012-03-22 | ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティ | Modulator of aldehyde dehydrogenase and method of use thereof |
JP2012508165A (en) * | 2008-11-07 | 2012-04-05 | イスティテュート ビオキーミコ ナッツィオナーレ サーヴィオ エスアールエル | α-Lipoic acid derivatives and their use in drug formulations |
JP5564512B2 (en) | 2008-11-24 | 2014-07-30 | セダーズ−シナイ メディカル センター | Antioxidant camptothecin derivatives and their antioxidant and anti-neoplastic nanospheres |
TW201119651A (en) * | 2009-10-26 | 2011-06-16 | Lg Life Sciences Ltd | Pharmaceutical composition comprising indole compound |
WO2012021791A2 (en) * | 2010-08-13 | 2012-02-16 | Scidose Llc | Aqueous formulation with improved stability |
US10457659B2 (en) | 2011-04-29 | 2019-10-29 | The Board Of Trustees Of The Leland Stanford Junior University | Compositions and methods for increasing proliferation of adult salivary stem cells |
WO2013024320A1 (en) * | 2011-08-17 | 2013-02-21 | Mahesh Kandula | 2, 6 xylidine derivatives for the treatment of pain |
EP2925719A4 (en) * | 2012-11-28 | 2016-07-13 | Yansong Lu | Novel synthetic antioxidants and their uses |
KR20150135332A (en) | 2013-03-14 | 2015-12-02 | 더 보드 오브 트러스티스 오브 더 리랜드 스탠포드 쥬니어 유니버시티 | Mitochondrial aldehyde dehydrogenase-2 modulators and methods of use thereof |
US10501741B2 (en) | 2014-06-25 | 2019-12-10 | Cold Spring Harbor Laboratory | Methods and compositions for inhibiting growth and epithelial to mesenchymal transition (EMT) in cancer cells |
WO2016126662A1 (en) * | 2015-02-03 | 2016-08-11 | Kardiatonos, Inc. | Compounds for the prevention and treatment of vascular disease |
MY196370A (en) | 2018-12-05 | 2023-03-27 | Celagenex Res India Pvt Ltd | Synergistic Compositions Of Bioactive Agents For Optimizing Cellular Health |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4808480A (en) | 1986-11-25 | 1989-02-28 | Lehigh University | Polymerizable heterocyclic disulfide-based compounds and membranes made therefrom |
GR1001503B (en) * | 1989-11-09 | 1994-02-28 | Asta Pharma Ag | Method for the preparation of pharmaceutical compounds containing carbonic acids containing sulphur and the use thereof in fighting retroviruses. |
DE4417038A1 (en) | 1994-05-14 | 1995-11-16 | Carl Heinrich Dr Weischer | New retinyl lipoate esters |
IL120531A (en) | 1997-03-26 | 2006-12-31 | Yissum Res Dev Co | Nitric oxide donors and pharmaceutical compositions containing them |
AU728488B2 (en) * | 1997-04-02 | 2001-01-11 | Sankyo Company Limited | Dithiolan derivatives, their preparation and their therapeutic effect |
EP1124820B1 (en) * | 1998-10-26 | 2004-09-22 | The Research Foundation Of State University Of New York | Lipoic acid derivatives and their use in treatment of disease |
US6204288B1 (en) * | 1999-03-08 | 2001-03-20 | The University Of Mississippi | 1,2-dithiolane derivatives |
DE19941217A1 (en) * | 1999-08-30 | 2001-03-15 | Asta Medica Ag | Treatment of migraines by administration of alpha-lipoic acid or derivatives thereof |
AU7995300A (en) * | 1999-10-05 | 2001-05-10 | Bethesda Pharmaceuticals, Inc. | Dithiolane derivatives |
US6387945B2 (en) * | 2000-04-11 | 2002-05-14 | The Regents Of The University Of California | Lipoic acid analogs |
-
1999
- 1999-11-25 JP JP2000583888A patent/JP2002530396A/en not_active Withdrawn
- 1999-11-25 US US09/856,616 patent/US6900338B1/en not_active Expired - Fee Related
- 1999-11-25 CA CA002352144A patent/CA2352144A1/en not_active Abandoned
- 1999-11-25 DE DE69920260T patent/DE69920260T2/en not_active Expired - Fee Related
- 1999-11-25 WO PCT/IL1999/000638 patent/WO2000031060A1/en active IP Right Grant
- 1999-11-25 AT AT99972629T patent/ATE276241T1/en not_active IP Right Cessation
- 1999-11-25 IL IL14333299A patent/IL143332A0/en active IP Right Grant
- 1999-11-25 AU AU14064/00A patent/AU775388B2/en not_active Ceased
- 1999-11-25 EP EP99972629A patent/EP1133487B1/en not_active Expired - Lifetime
Also Published As
Publication number | Publication date |
---|---|
EP1133487B1 (en) | 2004-09-15 |
DE69920260T2 (en) | 2005-10-06 |
EP1133487A1 (en) | 2001-09-19 |
JP2002530396A (en) | 2002-09-17 |
AU1406400A (en) | 2000-06-13 |
AU775388B2 (en) | 2004-07-29 |
CA2352144A1 (en) | 2000-06-02 |
DE69920260D1 (en) | 2004-10-21 |
WO2000031060A1 (en) | 2000-06-02 |
US6900338B1 (en) | 2005-05-31 |
ATE276241T1 (en) | 2004-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL143332A0 (en) | Scavenger compounds | |
IL129592A0 (en) | 5-HT1f agonists | |
MX9702865A (en) | 2-phenyl-1-[4-(2-aminoethoxy)-benzyl]-idoles as estrogenic agents. | |
MXPA04002931A (en) | Phenyl substituted 5-membered nitrogen containing heterocycles for the treatment of obesity. | |
DE69738815D1 (en) | Use of cyclooxygenase-2 inhibitors for the treatment and prevention of neoplasia | |
BG105270A (en) | Tetrahydropyridoethers | |
HK1068136A1 (en) | Muscarinic antagonists | |
ZA200202518B (en) | Certain alkylene diamine-substituted heterocycles. | |
CY2098B1 (en) | Phenyl heterocycles as cyclooxygenase-2 inhibitors | |
NZ237023A (en) | 17beta-substituted-4-aza-5alpha-androstan-3-ones and pharmaceutical compositions | |
EA200100516A1 (en) | DERIVATIVES 3,3-BIARILPIPERIDINA AND 2,2-BIARYLMORPHOLINE | |
CY1109950T1 (en) | NEW PRODUCTS OF 4,4-DYPHYTHODES- (3-AMINOBUTANIUM-1-SULPHONIC) AND COMPOSITIONS CONTAINING THEM | |
NO994584D0 (en) | Tetrahydropyridforbindelser | |
IL126235A (en) | Compounds with growth hormone releasing properties, pharmaceutical compositions comprising them and their use | |
DE69715173D1 (en) | Bisarylcyclobutenderivate als cyclooxygenasehemmer | |
ID25478A (en) | AGONIC 5-HT1F | |
BR9914895A (en) | Compositions comprising a mixture of bioflavonols | |
IL164536A0 (en) | The use of hydroxypyridone-derivatives in wound healing | |
MY138319A (en) | 1,5-benzodiazepine derivatives | |
HK1082727A1 (en) | 2" oxo-voruscharin and derivatives thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FF | Patent granted | ||
KB | Patent renewed |